Up to 10.30 and about to present 17 posters at the genetics conference, 17! That's a whole lot of active research going on. My other small bios seldom present more than 3 posters. As they keep expanding their knowledge base, they keep expanding the # of maladies they can address. More and more, oncologists are working to match tumor sequences with specific treatments. That puts NVTA in the spotlight. Growing really fast!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.